Rakuten Medical funnels 95% of its resources into U.S. 'lightsaber' cancer fight
CEO Minami Maeda is running Phase 3 trials and targeting a 2028 FDA submission as photoimmunotherapy moves from Japanese clinics toward the world's largest market.

Loading the Newsroom
Curating from trusted global sources…
5 briefings · “running”
CEO Minami Maeda is running Phase 3 trials and targeting a 2028 FDA submission as photoimmunotherapy moves from Japanese clinics toward the world's largest market.
Peter Steinberger, the developer behind the open-source AI agent OpenClaw and now an OpenAI employee, revealed the eye-watering cost of running AI agents at scale at Cloudflare's Connect conference.
New global analysis finds 25% of data centers already face water stress for at least one month a year - and climate change could push that to one-third.
The AI buildout is running on borrowed money, and the question of who's on the hook is getting louder. Here's what a crash would mean for companies, lenders, and taxpayers.
David Ellison's original production company name will brand the combined studio, a signal of who is really running the show.